Collegium Pharmaceutical, Inc.
NASDAQ:COLL
33.34 (USD) • At close January 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 159.301 | 145.276 | 144.923 | 149.745 | 136.709 | 135.546 | 144.767 | 129.62 | 127.013 | 123.549 | 83.751 | 27.362 | 78.843 | 82.942 | 87.721 | 76.271 | 79.176 | 78.058 | 76.511 | 74.203 | 72.942 | 75.04 | 74.516 | 73.427 | 70.176 | 73.061 | 63.749 | 10.794 | 11.95 | 3.56 | 2.172 | 1.303 | 0.408 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 62.507 | 54.47 | 53.467 | 55.115 | 56.398 | 61.72 | 67.365 | 79.831 | 68.174 | 71.185 | 35.255 | 28.695 | 32.73 | 32.703 | 32.123 | 31.979 | 30.983 | 29.694 | 37.524 | 49.088 | 46.754 | 48.654 | 49.164 | 29.726 | 46.007 | 46.838 | 43.106 | 1.094 | 0.553 | 0.577 | 0.371 | 0.184 | 0.029 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 96.794 | 90.806 | 91.456 | 94.63 | 80.311 | 73.826 | 77.402 | 49.789 | 58.839 | 52.364 | 48.496 | -1.333 | 46.113 | 50.239 | 55.598 | 44.292 | 48.193 | 48.364 | 38.987 | 25.115 | 26.188 | 26.386 | 25.352 | 43.701 | 24.169 | 26.223 | 20.643 | 9.7 | 11.397 | 2.983 | 1.801 | 1.119 | 0.379 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.608 | 0.625 | 0.631 | 0.632 | 0.587 | 0.545 | 0.535 | 0.384 | 0.463 | 0.424 | 0.579 | -0.049 | 0.585 | 0.606 | 0.634 | 0.581 | 0.609 | 0.62 | 0.51 | 0.338 | 0.359 | 0.352 | 0.34 | 0.595 | 0.344 | 0.359 | 0.324 | 0.899 | 0.954 | 0.838 | 0.829 | 0.859 | 0.929 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.983 | 0 | 0 | 3.983 | 1.609 | 1.45 | 3.462 | 2.93 | 2.472 | 2.141 | 2.493 | 2.666 | 2.398 | 2.491 | 2.459 | 2.992 | 2.249 | 1.907 | 2.237 | 2.268 | 2.194 | 2.069 | 2.179 | 2.13 | 3.331 | 3.254 | 4.301 | 4.062 | 1.531 | 3.358 | 1.641 | 1.445 | 2.307 | 5.818 | 3.565 | 3.269 |
| General & Administrative Expenses
| 0 | 0 | 0 | 25.536 | 0 | 0 | 0 | 26.289 | 0 | 0 | 0 | 22.416 | 0 | 0 | 0 | 113.832 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.905 | 5.907 | 2.934 | 2.185 | 1.02 | 0.687 | 0.523 | 0.475 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 7.406 | 0 | 0 | 0 | 11.743 | 0 | 0 | 0 | 4.186 | 0 | 0 | 0 | -87.008 | 26.426 | 29.322 | 31.26 | 25.09 | 30.072 | 28.935 | 32.352 | 30.451 | 33.448 | 31.279 | 31.582 | 25.089 | 22.758 | 22.062 | 22.847 | 25.367 | 23.567 | 20.173 | 11.525 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 61.955 | 43.335 | 41.982 | 32.942 | 35.298 | 38.193 | 52.775 | 38.032 | 38.372 | 41.254 | 54.528 | 26.602 | 30.514 | 30.368 | 31.476 | 26.824 | 26.426 | 29.322 | 31.26 | 25.09 | 30.072 | 28.935 | 32.352 | 30.451 | 33.448 | 31.279 | 31.582 | 25.089 | 22.758 | 22.062 | 22.847 | 25.367 | 23.567 | 20.173 | 11.525 | 7.905 | 5.907 | 2.934 | 2.185 | 1.02 | 0.687 | 0.523 | 0.475 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.983 | 0 | 0 | 0 | 14.029 | 0 | 0 | 0 | 9.772 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | -0.089 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 61.955 | 43.335 | 41.982 | 32.942 | 35.298 | 38.193 | 52.775 | 38.032 | 38.372 | 41.254 | 58.511 | 28.211 | 31.964 | 33.83 | 34.406 | 29.296 | 28.567 | 31.815 | 33.926 | 27.488 | 32.563 | 31.394 | 35.344 | 32.7 | 35.355 | 33.516 | 33.85 | 27.283 | 24.827 | 24.241 | 24.977 | 28.698 | 26.821 | 24.474 | 15.587 | 9.436 | 9.265 | 4.575 | 3.63 | 3.327 | 6.505 | 4.088 | 3.744 |
| Operating Income
| 34.839 | 47.471 | 49.474 | 61.688 | 45.013 | 35.633 | 24.627 | -30.32 | 20.467 | 11.11 | -10.011 | -34.122 | 14.149 | 16.409 | 21.192 | 14.996 | 19.626 | 16.549 | 5.061 | -2.373 | -6.375 | -5.008 | -9.992 | 11.001 | -11.186 | -7.293 | -13.207 | -17.583 | -13.43 | -21.258 | -23.176 | -27.579 | -26.442 | -24.474 | -15.587 | -9.436 | -9.265 | -4.575 | -3.63 | -3.327 | -6.505 | -4.088 | -3.744 |
| Operating Income Ratio
| 0.219 | 0.327 | 0.341 | 0.412 | 0.329 | 0.263 | 0.17 | -0.234 | 0.161 | 0.09 | -0.12 | -1.247 | 0.179 | 0.198 | 0.242 | 0.197 | 0.248 | 0.212 | 0.066 | -0.032 | -0.087 | -0.067 | -0.134 | 0.15 | -0.159 | -0.1 | -0.207 | -1.629 | -1.124 | -5.971 | -10.67 | -21.166 | -64.809 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -19.259 | -18.374 | -12.852 | -14.978 | -16.23 | -17.836 | -42.184 | -19.548 | -19.035 | -17.756 | -5.827 | -4.754 | -5.112 | -5.418 | -5.718 | -7.734 | -8.06 | -8.245 | -4.611 | 0.172 | 0.266 | 0.296 | 0.292 | -1.915 | -5.316 | -5.767 | -5.445 | 0.18 | 0.167 | 0.137 | 0.098 | 0.02 | -0.002 | -0.046 | -0.066 | -0.089 | -0.097 | -0.099 | -0.064 | -0.142 | -0.051 | -0.029 | -0.029 |
| Income Before Tax
| 15.58 | 29.097 | 36.622 | 46.71 | 28.783 | 17.797 | -17.557 | -7.791 | 1.432 | -6.646 | -15.842 | -38.876 | 9.037 | 10.991 | 15.474 | 7.262 | 11.566 | 8.304 | 0.45 | -2.201 | -6.109 | -4.712 | -9.7 | 9.086 | -16.502 | -13.06 | -18.652 | -17.403 | -13.263 | -21.121 | -23.078 | -27.559 | -26.444 | -24.52 | -15.653 | -9.525 | -9.362 | -4.674 | -3.694 | -3.469 | -6.556 | -4.117 | -3.773 |
| Income Before Tax Ratio
| 0.098 | 0.2 | 0.253 | 0.312 | 0.211 | 0.131 | -0.121 | -0.06 | 0.011 | -0.054 | -0.189 | -1.421 | 0.115 | 0.133 | 0.176 | 0.095 | 0.146 | 0.106 | 0.006 | -0.03 | -0.084 | -0.063 | -0.13 | 0.124 | -0.235 | -0.179 | -0.293 | -1.612 | -1.11 | -5.933 | -10.625 | -21.15 | -64.814 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 6.245 | 9.491 | 8.909 | 14.77 | 8.149 | 4.79 | -0.131 | -0.592 | 0.975 | -1.455 | -2.773 | -13.842 | 0.991 | -61.852 | -0.188 | 0.304 | 0.28 | 0.246 | 4.611 | 0.211 | -0.266 | -0.296 | -0.292 | 1.915 | 5.868 | 6.158 | 5.7 | -0.36 | -0.334 | -0.274 | -0.196 | -0.019 | 0.002 | 0.046 | 0.066 | 0.089 | 0.097 | 0.099 | -0.091 | 0.142 | 0.051 | 0.029 | 0.029 |
| Net Income
| 9.335 | 19.606 | 27.713 | 31.94 | 20.634 | 13.007 | -17.426 | -7.199 | 0.457 | -5.191 | -13.069 | -25.034 | 8.046 | 72.843 | 15.662 | 6.958 | 11.286 | 8.058 | 0.45 | -2.201 | -6.109 | -4.712 | -9.7 | 9.086 | -16.502 | -13.06 | -18.652 | -17.403 | -13.263 | -21.121 | -23.078 | -27.559 | -26.444 | -24.52 | -15.653 | -9.525 | -9.362 | -4.674 | -3.694 | -3.469 | -6.556 | -4.117 | -3.773 |
| Net Income Ratio
| 0.059 | 0.135 | 0.191 | 0.213 | 0.151 | 0.096 | -0.12 | -0.056 | 0.004 | -0.042 | -0.156 | -0.915 | 0.102 | 0.878 | 0.179 | 0.091 | 0.143 | 0.103 | 0.006 | -0.03 | -0.084 | -0.063 | -0.13 | 0.124 | -0.235 | -0.179 | -0.293 | -1.612 | -1.11 | -5.933 | -10.625 | -21.15 | -64.814 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0.33 | 0.6 | 0.86 | 0.99 | 0.61 | 0.38 | -0.51 | -0.21 | 0.013 | -0.15 | -0.39 | -0.73 | 0.23 | 2.06 | 0.45 | 0.2 | 0.33 | 0.23 | 0.01 | -0.066 | -0.18 | -0.14 | -0.29 | 0.27 | -0.5 | -0.4 | -0.57 | -0.54 | -0.45 | -0.72 | -0.79 | -1.02 | -1.13 | -1.05 | -0.68 | -0.46 | -0.46 | -0.4 | -0.19 | -0.46 | -0.88 | -0.55 | -0.5 |
| EPS Diluted
| 0.27 | 0.52 | 0.71 | 0.82 | 0.53 | 0.34 | -0.51 | -0.21 | 0.013 | -0.15 | -0.39 | -0.73 | 0.22 | 1.79 | 0.41 | 0.2 | 0.32 | 0.23 | 0.01 | -0.066 | -0.18 | -0.14 | -0.29 | 0.27 | -0.5 | -0.4 | -0.57 | -0.53 | -0.45 | -0.72 | -0.79 | -1.02 | -1.13 | -1.05 | -0.68 | -0.46 | -0.46 | -0.4 | -0.19 | -0.46 | -0.88 | -0.55 | -0.5 |
| EBITDA
| 75.721 | 80.151 | 89.395 | 101.454 | 86.658 | 77.91 | 42.048 | 50.999 | 58.43 | 49.543 | 9.785 | -16.902 | 31.401 | 33.64 | 38.436 | 32.075 | 36.619 | 33.554 | 15.766 | 1.798 | -2.013 | -0.617 | -5.594 | 27.326 | 21.927 | 25.601 | 17.056 | -17.273 | -13.131 | -20.997 | -22.87 | -27.283 | -26.169 | -24.43 | -15.544 | -9.395 | -9.227 | -4.529 | -3.493 | -3.281 | -6.459 | -4.041 | -3.696 |
| EBITDA Ratio
| 0.475 | 0.571 | 0.586 | 0.678 | 0.634 | 0.576 | 0.454 | 0.099 | 0.461 | 0.399 | 0.115 | -1.08 | 0.398 | 0.405 | 0.438 | 0.197 | 0.463 | 0.43 | 0.206 | -0.027 | -0.028 | -0.008 | -0.075 | 0.156 | 0.312 | 0.35 | 0.268 | -1.617 | -1.113 | -5.937 | -10.575 | -21.166 | -64.14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |